TASE:EVGNBiotechsWe're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn RateMarch 13, 2023Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
TASE:KMDABiotechsIs Kamada (TLV:KMDA) Using Too Much Debt?January 26, 2023Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
TASE:KMDABiotechsWe Discuss Why Kamada Ltd.'s (TLV:KMDA) CEO Compensation May Be Closely ReviewedDecember 16, 2022Key Insights Kamada to hold its Annual General Meeting on 22 December 2022 CEO Amir London's total compensation...
TASE:BONSBiotechsIs Bonus BioGroup (TLV:BONS) In A Good Position To Deliver On Growth Plans?December 13, 2022Just because a business does not make any money, does not mean that the stock will go down. For example, although...
TASE:CBIBiotechsClal Biotechnology Industries Third Quarter 2022 Earnings: ₪0.015 loss per share (vs ₪0.12 loss in 3Q 2021)December 01, 2022Clal Biotechnology Industries ( TLV:CBI ) Third Quarter 2022 Results Key Financial Results Revenue: ₪5.70m (down 72...
TASE:CANFBiotechsCan-Fite BioPharma Third Quarter 2022 Earnings: US$0.003 loss per share (vs US$0.006 loss in 3Q 2021)November 27, 2022Can-Fite BioPharma ( TLV:CANF ) Third Quarter 2022 Results Key Financial Results Net loss: US$2.53m (loss narrowed by...
TASE:KMDABiotechsKamada Third Quarter 2022 Earnings: EPS: US$0.01 (vs US$0.02 loss in 3Q 2021)November 24, 2022Kamada ( TLV:KMDA ) Third Quarter 2022 Results Key Financial Results Revenue: US$32.2m (up 40% from 3Q 2021). Net...
TASE:EVGNBiotechsEvogene Third Quarter 2022 Earnings: US$0.16 loss per share (vs US$0.19 loss in 3Q 2021)November 22, 2022Evogene ( TLV:EVGN ) Third Quarter 2022 Results Key Financial Results Net loss: US$6.54m (loss narrowed by 14% from 3Q...
TASE:KMDABiotechsFurther weakness as Kamada (TLV:KMDA) drops 10% this week, taking three-year losses to 13%September 23, 2022For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...
TASE:BONSBiotechsBonus BioGroup Ltd.'s (TLV:BONS) most bullish insider is CEO Shai Meretzki, and their holdings value went up by 33% last weekAugust 18, 2022A look at the shareholders of Bonus BioGroup Ltd. ( TLV:BONS ) can tell us which group is most powerful. And the group...
TASE:CBIBiotechsCalculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)July 14, 2022How far off is Clal Biotechnology Industries Ltd. ( TLV:CBI ) from its intrinsic value? Using the most recent financial...
TASE:CANFBiotechsIs Can-Fite BioPharma (TLV:CANF) In A Good Position To Invest In Growth?June 30, 2022Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
TASE:BLRXBiotechsIs BioLineRx (TLV:BLRX) A Risky Investment?June 17, 2022The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
TASE:HDSTBiotechsHadasit Bio-Holdings (TLV:HDST) Strong Profits May Be Masking Some Underlying IssuesApril 01, 2022Hadasit Bio-Holdings Ltd's ( TLV:HDST ) healthy profit numbers didn't contain any surprises for investors. We think...